PNEUMOCONIOSIS
Clinical trials for PNEUMOCONIOSIS explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCONIOSIS trials appear
Sign up with your email to follow new studies for PNEUMOCONIOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a lung fibrosis drug help miners breathe easier?
Disease control Recruiting nowThis Phase 3 trial tests whether pirfenidone capsules can improve lung function in 272 people with pneumoconiosis, a lung disease caused by inhaling dust. Participants take the drug or a placebo three times daily for a year. The main goal is to see if lung function (measured by F…
Matched conditions: PNEUMOCONIOSIS
Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Phlegm test could finally silence chronic cough in lung patients
Symptom relief Recruiting nowThis study tests whether analyzing a patient's phlegm can help doctors choose better treatments for chronic cough in interstitial lung disease (ILD). About 120 adults with ILD and daily cough for at least 8 weeks will be randomly assigned to either phlegm-guided treatment or stan…
Matched conditions: PNEUMOCONIOSIS
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC